D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 59 Citations 10,359 150 World Ranking 2475 National Ranking 99

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Cancer

His primary areas of study are Immunology, Internal medicine, Cytokine, Septic shock and Gastroenterology. His Immunology study frequently involves adjacent topics like Transplantation. The various areas that Jacques Bienvenu examines in his Internal medicine study include Autoantibody and Beta 2-Glycoprotein I.

His research in Cytokine intersects with topics in Tumor necrosis factor alpha and Lymphoma. His study in Septic shock is interdisciplinary in nature, drawing from both Apoptosis, Immunosuppression, Intensive care and Regulation of gene expression. The Gastroenterology study combines topics in areas such as Incidence, Relative risk, Confidence interval, Toxicity and Prospective cohort study.

His most cited work include:

  • T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow (335 citations)
  • Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock (334 citations)
  • The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells (289 citations)

What are the main themes of his work throughout his whole career to date?

Jacques Bienvenu focuses on Immunology, Internal medicine, Gastroenterology, Cytokine and Pathology. His works in Septic shock, Allergy, Tumor necrosis factor alpha, Basophil activation and Autoantibody are all subjects of inquiry into Immunology. Jacques Bienvenu interconnects Immunosuppression, Shock, Intensive care and Monocyte in the investigation of issues within Septic shock.

His Internal medicine study combines topics in areas such as Endocrinology and Oncology. His Gastroenterology study integrates concerns from other disciplines, such as Odds ratio, Diffuse large B-cell lymphoma, Confidence interval, Stage and Prospective cohort study. As a part of the same scientific family, Jacques Bienvenu mostly works in the field of Cytokine, focusing on Whole blood and, on occasion, Flow cytometry.

He most often published in these fields:

  • Immunology (49.17%)
  • Internal medicine (29.83%)
  • Gastroenterology (13.81%)

What were the highlights of his more recent work (between 2010-2019)?

  • Immunology (49.17%)
  • Internal medicine (29.83%)
  • Gastroenterology (13.81%)

In recent papers he was focusing on the following fields of study:

His main research concerns Immunology, Internal medicine, Gastroenterology, Interleukin 21 and Allergy. While working on this project, Jacques Bienvenu studies both Immunology and Population. The study incorporates disciplines such as Tissue transglutaminase and Endocrinology in addition to Internal medicine.

The various areas that Jacques Bienvenu examines in his Gastroenterology study include Inflammatory bowel disease, Sirolimus, Inflammation, Pathology and Immunoassay. In his study, which falls under the umbrella issue of Interleukin 21, Natural killer T cell is strongly linked to Interleukin 12. His work on Food allergy as part of general Allergy study is frequently linked to Methylene blue, bridging the gap between disciplines.

Between 2010 and 2019, his most popular works were:

  • T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow (335 citations)
  • The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells (289 citations)
  • TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway (222 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Cancer

The scientist’s investigation covers issues in Immunology, Interleukin 12, Interleukin 21, Janus kinase 3 and Internal medicine. The study of Immunology is intertwined with the study of Cancer research in a number of ways. In his research on the topic of Interleukin 12, IL-2 receptor, CD40, Antigen-presenting cell and Natural killer cell is strongly related with Natural killer T cell.

His studies deal with areas such as Immunoassay and Endocrinology as well as Internal medicine. His work on Insulin as part of general Endocrinology study is frequently connected to Adipokine, Lipid profile, Adiponectin and Polyunsaturated fatty acid, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Lymphokine-activated killer cell research focuses on Cell biology and how it relates to Interleukin 15.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock

Guillaume Monneret;Alain Lepape;Nicolas Voirin;Julien Bohé.
Intensive Care Medicine (2006)

529 Citations

T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow

Cécile Daussy;Fabrice Faure;Katia Mayol;Sébastien Viel.
Journal of Experimental Medicine (2014)

464 Citations

The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells

Antoine Marçais;Julien Cherfils-Vicini;Charlotte Viant;Sophie Degouve.
Nature Immunology (2014)

444 Citations

TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

Sébastien Viel;Antoine Marçais;Fernando Souza Fonseca Guimaraes;Fernando Souza Fonseca Guimaraes;Roisin Loftus.
Science Signaling (2016)

406 Citations

Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.

Krzysztof Warzocha;Patricia Ribeiro;Jacques Bienvenu;Pascal Roy.
Blood (1998)

399 Citations

Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.

Guillaume Monneret;Anne-Lise Debard;Fabienne Venet;Julien Bohe.
Critical Care Medicine (2003)

376 Citations

The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration.

Guillaume Monneret;Marie-Emmanuelle Finck;Fabienne Venet;Anne-Lise Debard.
Immunology Letters (2004)

289 Citations

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.

Ewa Lech-Maranda;Lucile Baseggio;Jacques Bienvenu;Carole Charlot.
Blood (2004)

244 Citations

Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls

A.L. de Weck;M.L. Sanz;P.M. Gamboa;W. Aberer.
International Archives of Allergy and Immunology (2008)

235 Citations

Procalcitonin as an acute phase marker.

John Whicher;Jacques Bienvenu;Guillaume Monneret.
Annals of Clinical Biochemistry (2001)

234 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jacques Bienvenu

Fabienne Venet

Fabienne Venet

Claude Bernard University Lyon 1

Publications: 64

Karl-Johan Malmberg

Karl-Johan Malmberg

Oslo University Hospital

Publications: 42

Didier G. Ebo

Didier G. Ebo

University of Antwerp

Publications: 38

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 37

Guillaume Monneret

Guillaume Monneret

Hôpital Édouard-Herriot

Publications: 36

Nicholas D. Huntington

Nicholas D. Huntington

Monash University

Publications: 34

Chris H. Bridts

Chris H. Bridts

University of Antwerp

Publications: 30

Joseph C. Sun

Joseph C. Sun

Memorial Sloan Kettering Cancer Center

Publications: 26

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 25

Thierry Walzer

Thierry Walzer

Claude Bernard University Lyon 1

Publications: 24

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 23

Cristobalina Mayorga

Cristobalina Mayorga

University of Malaga

Publications: 23

Gabrielle T. Belz

Gabrielle T. Belz

University of Queensland

Publications: 23

James P. Di Santo

James P. Di Santo

Université Paris Cité

Publications: 22

Marco Colonna

Marco Colonna

Washington University in St. Louis

Publications: 20

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 20

Trending Scientists

Maria Domenica Di Benedetto

Maria Domenica Di Benedetto

University of L'Aquila

Min Sun

Min Sun

National Tsing Hua University

Raikko Kivekäs

Raikko Kivekäs

University of Helsinki

Nikolay K. Kochetkov

Nikolay K. Kochetkov

Russian Academy of Sciences

Hideki Sakurai

Hideki Sakurai

Tokyo University of Science

Virginia Walbot

Virginia Walbot

Stanford University

Hiroyasu Esumi

Hiroyasu Esumi

Tokyo University of Science

Anne Boland

Anne Boland

University of Paris-Saclay

Susan Ivy-Ochs

Susan Ivy-Ochs

ETH Zurich

Norman G. Loeb

Norman G. Loeb

Langley Research Center

Frank Scholten

Frank Scholten

German Aerospace Center

Craig Murray

Craig Murray

Lancaster University

Paul D. Stein

Paul D. Stein

Michigan State University

Anders Larsson

Anders Larsson

Uppsala University

Alicia J. Jenkins

Alicia J. Jenkins

University of Sydney

Malcolm M Feeley

Malcolm M Feeley

University of California, Berkeley

Something went wrong. Please try again later.